Prime Medicine, Inc. (PRME)
4.295
-0.36
(-7.63%)
USD |
NASDAQ |
Nov 09, 16:00
4.29
0.00 (0.00%)
After-Hours: 19:29
Prime Medicine Total Return Level : 4.65 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 4.65 |
| November 05, 2026 | 4.45 |
| November 04, 2026 | 4.97 |
| November 03, 2026 | 4.55 |
| November 02, 2026 | 4.44 |
| October 30, 2026 | 4.72 |
| October 29, 2026 | 5.24 |
| October 28, 2026 | 5.36 |
| October 27, 2026 | 4.35 |
| October 26, 2026 | 3.61 |
| October 23, 2026 | 3.67 |
| October 22, 2026 | 3.73 |
| October 21, 2026 | 3.81 |
| October 20, 2026 | 3.92 |
| October 19, 2026 | 3.83 |
| October 16, 2026 | 3.47 |
| October 15, 2026 | 3.61 |
| October 14, 2026 | 3.13 |
| October 13, 2026 | 3.32 |
| October 12, 2026 | 3.61 |
| October 09, 2026 | 3.99 |
| October 08, 2026 | 3.58 |
| October 07, 2026 | 3.90 |
| October 06, 2026 | 3.50 |
| October 05, 2026 | 3.21 |
| Date | Value |
|---|---|
| October 02, 2026 | 2.98 |
| October 01, 2026 | 2.99 |
| September 30, 2026 | 3.055 |
| September 29, 2026 | 3.09 |
| September 28, 2026 | 2.875 |
| September 25, 2026 | 2.90 |
| September 24, 2026 | 3.07 |
| September 23, 2026 | 3.13 |
| September 22, 2026 | 3.54 |
| September 21, 2026 | 3.19 |
| September 18, 2026 | 3.12 |
| September 17, 2026 | 3.14 |
| September 16, 2026 | 3.00 |
| September 15, 2026 | 3.14 |
| September 14, 2026 | 3.18 |
| September 11, 2026 | 3.13 |
| September 10, 2026 | 3.35 |
| September 09, 2026 | 3.47 |
| September 08, 2026 | 3.56 |
| September 04, 2026 | 3.70 |
| September 03, 2026 | 3.71 |
| September 02, 2026 | 3.67 |
| September 01, 2026 | 3.57 |
| August 31, 2026 | 3.59 |
| August 28, 2026 | 3.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Intellia Therapeutics, Inc. | 11.35 |
| Beam Therapeutics, Inc. | 26.41 |
| Twist Bioscience Corp. | 120.79 |
| Moderna, Inc. | 254.19 |
| Q32 Bio, Inc. | 9.25 |